Status:
COMPLETED
Vitamin D in Fatty Liver Disease
Lead Sponsor:
University Hospital Rijeka
Collaborating Sponsors:
University of Rijeka
Pliva Hrvatska d.o.o.
Conditions:
Non-alcoholic Fatty Liver Disease
Vitamin D Deficiency
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This study evaluates the influence of vitamin D in reducing laboratory, elastographic (Fibroscan) and metabolic components of NAFLD. Half of the patients will receive vitamin D (Plivit D3) while the o...
Detailed Description
In this study will participate patients who come to the regular ambulatory examinations (referred by gastroenterologists, or family physicians in the Department of Gastroenterology CHC Rijeka) and hav...
Eligibility Criteria
Inclusion
- patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
- signed informed consent
- possibility to follow instruction and the protocol
Exclusion
- chronic B or C hepatitis
- usage of hepatotoxic drugs in the period of 6 months before inclusion
- chronic kidney insufficiency (grade 4 and 5), hemodialysis
- any other chronic liver disease
- opioid dependancy
- any malignancy
- HIV seropositivity
- alcohol abuse
- pregnancy
- inability to follow the protocol
Key Trial Info
Start Date :
December 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04038853
Start Date
December 1 2015
End Date
April 1 2019
Last Update
July 31 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.